Lv1
40 积分 2024-07-20 加入
Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study
1个月前
已完结
Multiparametric MRI for characterization of the tumour microenvironment
2个月前
已完结
基于时间扩散谱的定量MRI技术研究进展
2个月前
已完结
Safety and efficacy of microwave versus radiofrequency ablation for large hepatic hemangioma: a multicenter retrospective study with propensity score matching
5个月前
已完结
Safety and effective of laparoscopic microwave ablation for giant hepatic hemangioma: a retrospective cohort study
5个月前
已完结
皖公网安备34019202002308
